ERD-308
Kategoria produktu: Biznes i przemysł > Badania naukowe i laboratoryjne
Sprzedawca:Gentaur
ERD-308 is a highly potent von Hippel-Lindau-based PROTAC degrader of estrogen receptor (ER) for ER positive breast cancer treatment. ERD-308 induces >95% of ER degradation at concentrations as low as 5 nM in both cell lines (DC50 (concentration causing 50% of protein degradation) of 0.17 nM and 0.43 nM in MCF-7 and T47D ER+ cells, respectively)[1].
Specyfikacja/Zawartość:
- CAS number: 2320561-35-9
- Purity: 99.17
- Formula: C55H65N5O9S2
- Solubility: DMSO : 50 mg/mL (ultrasonic)
- SMILES: O=C(C1=C(C2=CC=C(O)C=C2)SC3=CC(O)=CC=C13)C4=CC=C(OCCN(CCCCCOCC(N[C@@H](C(C)(C)C)C(N5[C@H](C(N[C@@H](C)C6=CC=C(C7=C(C)N=CS7)C=C6)=O)C[C@@H](O)C5)=O)=O)CC)C=C4
- Molecular Weight: 1004.26
- Applications: Cancer-programmed cell death
Wysyłka i przechowywanie:
4°C (Powder, protect from light)
Inne:
For research use only. Not to be used for human or animal treatment or consumption.
0 opinie o ERD-308